Citation only
via OpenAlex
Association of α‐synuclein Rep1 polymorphism and Parkinson's disease: Influence of Rep1 on age at onset
Georgios M. Hadjigeorgiou, Georgia Xiromerisiou, Vanessa Gourbali, Kostantinos Aggelakis, Nikolaos Scarmeas, Alexandros Papadimitriou, Andrew Singleton
Movement Disorders · 2005 · ▲ 51 citations
Abstract
The alpha-synuclein Rep1 polymorphism was studied in patients and controls in an ethnic Greek population. There was an association of allele 2 with risk of Parkinson's disease (PD; adjusted odd ratio = 3.25; 95% CI = 1.80-5.87). Survival analyses (Cox proportional hazards models) were employed to explore the influence of genotypes on age at onset of PD. Age at onset of carriers of at least one Rep1 allele 2 was earlier (3.6 years) compared to noncarriers (adjusted hazard ratio = 2.21; 95% CI = 1.58-3.10). Kaplan-Meier analysis also supported a dosage effect of Rep1 allele 2 on age at onset. For Rep1 allele 1, there was neither association with risk of PD nor influence on age at onset. This is the first study showing an influence of Rep1 polymorphism on age at onset of PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/mds.20752
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Hadjigeorgiou, G.M., Xiromerisiou, G., Gourbali, V., Aggelakis, K., Scarmeas, N., Papadimitriou, A., & Singleton, A. (2005). Association of α‐synuclein Rep1 polymorphism and Parkinson's disease: Influence of Rep1 on age at onset. <em>Movement Disorders</em>. https://doi.org/10.1002/mds.20752
Vancouver
Hadjigeorgiou GM, Xiromerisiou G, Gourbali V, Aggelakis K, Scarmeas N, Papadimitriou A, et al. Association of α‐synuclein Rep1 polymorphism and Parkinson's disease: Influence of Rep1 on age at onset. Movement Disorders. 2005. doi:10.1002/mds.20752.
BibTeX
@article{georgios2005Associ,
title = {Association of α‐synuclein Rep1 polymorphism and Parkinson's disease: Influence of Rep1 on age at onset},
author = {Georgios M. Hadjigeorgiou and Georgia Xiromerisiou and Vanessa Gourbali and Kostantinos Aggelakis and Nikolaos Scarmeas and Alexandros Papadimitriou and Andrew Singleton},
journal = {Movement Disorders},
year = {2005},
doi = {10.1002/mds.20752},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nutrition Research 2017
Citation only
Protein and exercise in the prevention of sarcopenia and aging
University of Zurich 2018
Open access · US-GOV
Sarcopenia Prevention With a Targeted Exercise and Protein Supplementation Program
Movement Disorders 2014
Open access · OA
Alpha‐synuclein repeat variants and survival in Parkinson's disease
Journal of Thrombosis and Haemostasis 2007
Open access · OA
Inflammatory/hemostatic biomarkers and cardiovascular risk: coming of age?
Movement Disorders 2019
Open access · OA
Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms
Movement Disorders 2009
Citation only